Edesa Biotech Inc

General ticker "EDSA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $6.6M

Edesa Biotech Inc does not follow the US Stock Market performance with the rate: -30.9%.

Estimated limits based on current volatility of 4.7%: low 1.69$, high 1.87$

Factors to consider:

  • Current price 50.8% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-09-30 to 2025-09-29

  • 2023-09-30 to 2024-09-29 estimated range: [3.62$, 8.74$]
  • 2024-09-29 to 2025-09-29 estimated range: [3.52$, 8.26$]

Financial Metrics affecting the EDSA estimates:

  • Negative: Non-GAAP EPS, $ of -2.52 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -27.82 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term EDSA quotes

Long-term EDSA plot with estimates

Financial data

YTD 2022-09-30 2023-09-30 2024-09-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $18.37MM $9.22MM $7.01MM
Operating Income $-18.37MM $-9.22MM $-7.01MM
Non-Operating Income $0.82MM $0.85MM $0.85MM
R&D Expense $13.34MM $4.79MM $2.88MM
Income(Loss) $-17.55MM $-8.37MM $-6.17MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss) $-17.55MM $-8.37MM $-6.17MM
Stockholders Equity $9.39MM $7.05MM $1.98MM
Inventory $1.26MM $0.00MM $0.00MM
Assets $11.58MM $8.89MM $3.81MM
Operating Cash Flow $-12.28MM $-6.64MM $-4.89MM
Capital expenditure $0.01MM $0.00MM $0.00MM
Investing Cash Flow $-0.01MM $0.00MM $0.00MM
Financing Cash Flow $11.63MM $4.83MM $0.59MM
Earnings Per Share* $-8.37 $-2.93 $-1.93

* EPS are Split Adjusted, recent splits may be reflected with a delay.